Fondos más rentables del año

Inicio Versión Clásica Menú
  1. Inicio
  2. Fondos de Inversión
  3. Ranking
  4. Rentabilidad en el año

Rentabilidad en el año

Resultado de la búsqueda: Resumen
FondoFecha
2026
Resultados por página: 10 | 20 | 50 | 100Se muestran de 35201 a 35300 de un total de 36967 fondos
UBS (LUX) DIGITAL HEALTH EQUITY SEEDING P-ACC30/03-11,96%
BELLEVUE FUNDS (LUX) - BELLEVUE DIGITAL HEALTH B USD31/03-11,97%
INVESCO EMERGING MARKETS LOCAL DEBT Z DIS ANNUAL EUR (HEDGED)31/03-11,97%
MSIF GLOBAL OPPORTUNITY I (EUR)31/03-11,97%
SCHRODER ISF INDIAN OPPORTUNITIES I ACC USD30/03-11,97%
SEILERN INTERNATIONAL FUNDS PLC - SEILERN AMERICA USD U R31/03-11,97%
FAST-EUROPE FUND A-PF-ACC-EUR31/03-11,98%
THEMATICS SUBSCRIPTION ECONOMY H-N/A (EUR)31/03-11,98%
ISHARES DIGITALISATION UCITS ETF USD (ACC)31/03-11,99%
BELLEVUE FUNDS (LUX) - BELLEVUE DIGITAL HEALTH I2 EUR31/03-12,00%
BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES U CHF31/03-12,00%
BGF WORLD FINANCIALS A2 SGD (HEDGED)31/03-12,00%
UBS (LUX) DIGITAL HEALTH EQUITY QL-ACC30/03-12,00%
LOOMIS SAYLES U.S. GROWTH EQUITY H-S/A (EUR)31/03-12,01%
MSIF ASIA OPPORTUNITY ZH (EUR)31/03-12,01%
LO FUNDS - SOCIAL SYSTEMS CHANGE (USD) P CAP27/03-12,02%
LOOMIS SAYLES U.S. GROWTH EQUITY H-S1/A (EUR)31/03-12,02%
UBS (LUX) DIGITAL HEALTH EQUITY I-A1-ACC30/03-12,02%
UBS (LUX) DIGITAL HEALTH EQUITY I-A2-ACC30/03-12,02%
UBS (LUX) DIGITAL HEALTH EQUITY (JPY) I-A1-ACC30/03-12,02%
EDM RENTA VARIABLE INTERNACIONAL, FI30/03-12,03%
GESTION BOUTIQUE VIII / AUDAX30/03-12,03%
MSIF ASIA OPPORTUNITY IH (EUR)31/03-12,03%
UBS (LUX) DIGITAL HEALTH EQUITY Q-ACC30/03-12,03%
BELLEVUE FUNDS (LUX) - BELLEVUE DIGITAL HEALTH I EUR31/03-12,04%
BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES I CHF31/03-12,04%
GOLDMAN SACHS GLOBAL FUTURE GENERATIONS EQUITY PORTFOLIO OTHER CURRENCY EUR DIS31/03-12,06%
LOOMIS SAYLES U.S. GROWTH EQUITY H-I/A (EUR)31/03-12,07%
UBS (LUX) DIGITAL HEALTH EQUITY K-1-ACC30/03-12,07%
SCHRODER ISF GLOBAL DISRUPTION A ACC EUR (HEDGED)31/03-12,08%
AB SICAV I-CONCENTRATED GLOBAL EQUITY PORTFOLIO A EUR H31/03-12,09%
AB SICAV I-GLOBAL GROWTH PORTFOLIO A EUR H31/03-12,09%
BGF US GROWTH A2 EUR (HEDGED)31/03-12,09%
GOLDMAN SACHS GLOBAL FUTURE GENERATIONS EQUITY PORTFOLIO OTHER CURRENCY EUR CAP31/03-12,09%
LO FUNDS - SOCIAL SYSTEMS CHANGE (EUR) P CAP27/03-12,09%
FIDELITY FUNDS-GLOBAL CONSUMER BRANDS E-ACC-EUR31/03-12,10%
SCHRODER ISF INDIAN OPPORTUNITIES E ACC USD30/03-12,10%
BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES T CHF31/03-12,11%
BGF WORLD FINANCIALS A2 HKD (HEDGED)31/03-12,11%
CT (LUX) EUROPEAN SELECT 8EP EUR31/03-12,11%
EDM INTERNATIONAL - GLOBAL EQUITY IMPACT R EUR27/03-12,11%
THEMATICS SUBSCRIPTION ECONOMY H-R/A (EUR)31/03-12,11%
UBS (LUX) DIGITAL HEALTH EQUITY (EUR) P-DIST30/03-12,11%
MSIF GLOBAL OPPORTUNITY A (EUR)31/03-12,12%
SCHRODER ISF INDIAN OPPORTUNITIES IZ ACC USD30/03-12,12%
FINALTIS FUNDS - EUROPE SELECTION EUR CAP30/03-12,13%
UBS (LUX) EQUITY SICAV - USA GROWTH (USD) P-ACC30/03-12,14%
FAST-EUROPE FUND E-PF-ACC-EUR31/03-12,15%
SCHRODER ISF GLOBAL DISRUPTION B ACC EUR (HEDGED)31/03-12,16%
JPM US TECHNOLOGY I2 (ACC) USD31/03-12,17%
SCHRODER ISF INDIAN OPPORTUNITIES C ACC USD30/03-12,18%
BELLEVUE FUNDS (LUX) - BELLEVUE DIGITAL HEALTH B EUR31/03-12,19%
JPM US TECHNOLOGY C (ACC) USD31/03-12,19%
JPM US TECHNOLOGY I (ACC) USD31/03-12,19%
LO FUNDS - SOCIAL SYSTEMS CHANGE (USD) R CAP27/03-12,19%
ROBECO INDIAN EQUITIES I USD31/03-12,19%
BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES B CHF31/03-12,20%
JPM US TECHNOLOGY C (DIST) USD31/03-12,20%
CPR INVEST GLOBAL LIFESTYLES A EUR H ACC30/03-12,21%
MSIF GLOBAL BRANDS EQUITY INCOME IR (USD)31/03-12,21%
EXANE FUNDS 1 - EXANE OVERDRIVE FUND A EUR CAP30/03-12,22%
GOLDMAN SACHS GLOBAL FUTURE GENERATIONS EQUITY PORTFOLIO E EUR CAP31/03-12,22%
UBS (LUX) DIGITAL HEALTH EQUITY P-ACC30/03-12,22%
GOLDMAN SACHS GLOBAL FUTURE GENERATIONS EQUITY PORTFOLIO E EUR DIS31/03-12,23%
BL EQUITIES AMERICA BM EUR HEDGED CAP30/03-12,25%
BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES I GBP31/03-12,26%
MSIF ASIA OPPORTUNITY AH (EUR)31/03-12,26%
EDR SICAV-TRICOLORE CONVICTIONS CR EUR CAP30/03-12,27%
LOOMIS SAYLES U.S. GROWTH EQUITY H-R/A (EUR)31/03-12,27%
INVESCO STOXX EUROPE 600 OPTIMISED TRAVEL & LEISURE UCITS ETF ACC31/03-12,28%
UBS (LUX) SECURITY EQUITY (CHF HEDGED) QL-ACC30/03-12,30%
UBS (LUX) SECURITY EQUITY (CHF HEDGED) Q-ACC30/03-12,31%
UBS (LUX) SECURITY EQUITY (CHF HEDGED) I-A1-ACC30/03-12,32%
CT (LUX) EUROPEAN SELECT 1EP EUR31/03-12,33%
SCHRODER ISF INDIAN OPPORTUNITIES F ACC SGD30/03-12,33%
BL EQUITIES AMERICA B EUR HEDGED CAP30/03-12,34%
FIDELITY FUNDS-GLOBAL FOCUS Y-ACC-EUR (HEDGED)31/03-12,34%
SCHRODER ISF US LARGE CAP C ACC SEK (HEDGED)31/03-12,34%
EDR SICAV-TRICOLORE CONVICTIONS I EUR CAP30/03-12,35%
SCHRODER ISF INDIAN OPPORTUNITIES A ACC USD30/03-12,35%
COMGEST GROWTH EUROPE EUR I FIXED DIS30/03-12,36%
UBS (LUX) SECURITY EQUITY (CHF HEDGED) K-1-ACC30/03-12,36%
EDR SICAV-TRICOLORE CONVICTIONS K EUR CAP30/03-12,38%
ROBECO INDIAN EQUITIES D USD31/03-12,38%
JPM US TECHNOLOGY A (ACC) USD31/03-12,39%
JPM US TECHNOLOGY A (DIST) USD31/03-12,40%
ROBECO INDIAN EQUITIES I EUR31/03-12,41%
BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES U2 USD31/03-12,42%
CPR INVEST GLOBAL LIFESTYLES F EUR H ACC30/03-12,42%
UBAM - TECH GLOBAL LEADERS EQUITY IC USD30/03-12,42%
MSIF GLOBAL BRANDS EQUITY INCOME AR (USD)31/03-12,44%
COMGEST GROWTH EUROPE EUR FIXED DIS30/03-12,45%
UBS (LUX) DIGITAL HEALTH EQUITY N-ACC30/03-12,46%
BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES U USD31/03-12,48%
ISHARES US MEDICAL DEVICES UCITS ETF USD (ACC)31/03-12,48%
SCHRODER ISF US LARGE CAP A ACC PLN (HEDGED)31/03-12,48%
UBAM - TECH GLOBAL LEADERS EQUITY UC USD30/03-12,48%
BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES I2 USD31/03-12,49%
FIDELITY FUNDS-GLOBAL FOCUS A-ACC-EUR (HEDGED)31/03-12,51%
JANUS HENDERSON US FORTY H2 EUR HEDGED31/03-12,51%
  • Fondos de Inversión
    • Buscador de fondos
    • Ranking
      • 5 Estrellas VDOS
      • Rentabilidad en el año
      • Rentabilidad en 3 años
      • Rentabilidad en 5 años
  • Planes de Pensiones
© 2011 VDOS Stochastics | Información Legal | Contacto | Versión clásica Visitar VDOS